Provectus Biopharmaceuticals (PVCT) Non-Current Assets (2010 - 2026)
Provectus Biopharmaceuticals (PVCT) recorded Non-Current Assets of $104,617 in Q2 2026, down 32.1% from $154,064 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Provectus Biopharmaceuticals reported Non-Current Assets of $129,628, up 339.6% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $29,487 in FY2024 (-64.9%), $84,046 in FY2023 (-39.1%), $138,064 in FY2022 (+93.4%) and $71,399 in FY2021 (-56.9%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets since Q1 2025.
- On a year-over-year basis, Non-Current Assets rose in three of the last seven quarters, with growth averaging 74.5%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 339.6% in Q4 2025, against a decline of 76.1% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 104,617.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104,617.00 |
| Dec 31, 2025 | 129,628.00 |
| Sep 30, 2025 | 141,916.00 |
| Jun 30, 2025 | 154,064.00 |
| Mar 31, 2025 | 16,788.00 |
| Dec 31, 2024 | 29,487.00 |
| Sep 30, 2024 | 42,030.00 |
| Jun 30, 2024 | 56,183.00 |
| Mar 31, 2024 | 70,187.00 |
| Dec 31, 2023 | 84,046.00 |
| Sep 30, 2023 | 97,759.00 |
| Jun 30, 2023 | 111,331.00 |
| Mar 31, 2023 | 124,765.00 |
| Dec 31, 2022 | 138,064.00 |
| Sep 30, 2022 | 151,038.00 |
| Jun 30, 2022 | 164,662.00 |
| Mar 31, 2022 | 43,795.00 |
| Dec 31, 2021 | 71,399.00 |
| Sep 30, 2021 | 93,788.00 |
| Jun 30, 2021 | 119,078.00 |
API Access
Provectus Biopharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();